IDH1 and glioblastoma: Meta-regression analysis within the IDH-wildtype GBM cohort also revealed that MGMT methylated tumors were significantly less likely to have both neurologic (β = −4.4, p < 0.01) and non-neurologic complications (β = −3.5, p < 0.05) (Figure 2).